Psilocin crystalline forms
Application
US20260085039A1
Kind: A1
Mar 26, 2026
Inventors
Jim GILLIGAN, Peter GUZZO
Abstract
The present invention relates to crystalline forms of psilocin (4-hydroxy-N,N-dimethyltryptamine) salts or cocrystals, as well as compositions, methods of preparation and methods of their use. The present invention also relates to said crystalline forms having improved physical properties such as aqueous solubility and stability, wherein the crystalline forms and compositions thereof are suitable for oral, subcutaneous, intravenous, or intramuscular administration.
CPC Classifications
C07D 209/16
A61K 31/4045
C07C 53/124
C07C 55/10
C07C 57/15
C07C 59/255
C07C 59/265
C07C 63/08
C07C 309/29
C07B 2200/13
Filing Date
2023-09-12
Application No.
19110733